Therapeutics

Tools

Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Condition Approved
For
BAN2401 2 Biogen Idec, Eisai Co., Ltd. Amyloid-Related Immunotherapy (passive) Alzheimer's Disease
Bapineuzumab AAB-001 Discontinued Janssen, Pfizer Amyloid-Related Immunotherapy (passive) Alzheimer's Disease
BIIB037 1 Biogen Idec Amyloid-Related Immunotherapy (passive) Alzheimer's Disease
Crenezumab MABT5102A ,
RG7412
2 Genentech Amyloid-Related Immunotherapy (passive) Alzheimer's Disease None
Gammagard™ Intravenous Immunoglobulin,
IVIg
Discontinued Baxter Healthcare Amyloid-Related, Inflammation Immunotherapy (passive) Alzheimer's Disease Immunodeficiency conditions
Gamunex Intravenous Immunoglobulin,
Human Albumin Combined With Flebogamma
2/3 Grifols Biologicals Inc. Amyloid-Related, Inflammation Immunotherapy (passive) Alzheimer's Disease Immunodeficiency, chronic inflammatory demyelinating neuropathy
Gantenerumab RO4909832,
RG1450
3 Chugai Pharmaceutical Co., Ltd., Hoffmann-La Roche Amyloid-Related Immunotherapy (passive) Alzheimer's Disease
Octagam® Intravenous Immunoglobulin,
NewGam
2, 2 Octapharma Amyloid-Related, Inflammation Immunotherapy (passive) Alzheimer's Disease, Mild Cognitive Impairment
Ponezumab PF-04360365 Discontinued, 2 Pfizer Amyloid-Related Immunotherapy (passive) Alzheimer's Disease, Cerebral Amyloid Angiopathy None
SAR228810 1 Sanofi Amyloid-Related Immunotherapy (passive) Alzheimer's Disease
Solanezumab LY2062430 3 Eli Lilly & Co. Amyloid-Related Immunotherapy (passive) Alzheimer's Disease None